You're using a free limited version of DrugPatentWatch: Upgrade for Complete Access

Last Updated: November 23, 2024

CLINICAL TRIALS PROFILE FOR ADVATE

✉ Email this page to a colleague

« Back to Dashboard

All Clinical Trials for ADVATE

Subscribe to access the full database, or Sign Up
Trial ID	Title	Status	Sponsor	Phase	Start Date	Summary
NCT00168051 ↗	Study Comparing Blood Levels of ReFacto and Advante in Hemophilia A	Withdrawn	Wyeth is now a wholly owned subsidiary of Pfizer	Phase 4	2005-04-01	The purpose of the study is to compare the pharmacokinetic parameters of ReFacto and Advate, using the chromogenetic substrate assay to measure plasma Factor VIII activity in plasma.
NCT00189982 ↗	Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101	Completed	Baxalta now part of Shire	Phase 2/Phase 3	2004-12-17	The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of children with hemophilia A. The study is open to pediatric patients in Canada who completed Baxter Study 060101.
NCT00189982 ↗	Efficacy and Safety Study of a Recombinant and Protein-Free Factor VIII (rAHF-PFM) in Pediatric Patients in Canada With Hemophilia A - A Continuation of Baxter Study 060101	Completed	Baxalta US Inc.	Phase 2/Phase 3	2004-12-17	The purpose of this study is to evaluate whether rAHF-PFM is safe and effective in the treatment of children with hemophilia A. The study is open to pediatric patients in Canada who completed Baxter Study 060101.
>Trial ID	>Title	>Status	>Sponsor	>Phase	>Start Date	>Summary

Clinical Trial Conditions for ADVATE

Condition Name

Chart
Table

Condition Name for ADVATE
Intervention	Trials
Hemophilia A	14
Severe Hemophilia A	3
Haemophilia A	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Condition MeSH

Chart
Table

Condition MeSH for ADVATE
Intervention	Trials
Hemophilia A	20
Bone Diseases	1
Von Willebrand Diseases	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Locations for ADVATE

Trials by Country

Map
Table

Trials by Country for ADVATE
Location	Trials
United States	80
China	10
Italy	9
Germany	7
India	7
This preview shows a limited data set Subscribe for full access, or try a Trial

Trials by US State

Map
Table

Trials by US State for ADVATE
Location	Trials
California	6
Pennsylvania	5
Indiana	5
Louisiana	5
Texas	4
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Progress for ADVATE

Clinical Trial Phase

Chart
Table

Clinical Trial Phase for ADVATE
Clinical Trial Phase	Trials
Phase 4	6
Phase 3	3
Phase 2/Phase 3	1
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Status

Chart
Table

Clinical Trial Status for ADVATE
Clinical Trial Phase	Trials
Completed	12
Unknown status	3
Withdrawn	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Clinical Trial Sponsors for ADVATE

Sponsor Name

Chart
Table

Sponsor Name for ADVATE
Sponsor	Trials
Baxalta now part of Shire	5
Baxalta US Inc.	5
Jiangsu Gensciences lnc.	2
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Sponsor Type

Chart
Table

Sponsor Type for ADVATE
Sponsor	Trials
Industry	30
Other	11
[disabled in preview]	0
This preview shows a limited data set Subscribe for full access, or try a Trial

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.